Literature DB >> 1543394

Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein.

O Ishikawa1, H Ohigashi, S Imaoka, H Furukawa, Y Sasaki, M Fujita, C Kuroda, T Iwanaga.   

Abstract

This retrospective study attempted to determine the indications for extended pancreatectomy for locally advanced carcinoma of the pancreas, in terms of postoperative prognosis. An extended pancreatectomy with portal vein or superior mesenteric vein (PV/SMV) resection and regional lymphadenectomy was performed in 35 of 50 consecutive cancers that extended into the retroperitoneal spaces and involved the PV or SMV. Among the many background factors in the 35 resected specimens, the degree of PV/SMV invasion by the cancer was most closely associated with prognosis, despite resection of all involved PV/SMV. This factor generally correlated with the preoperative findings on the portal phase of superior mesenteric arteriograph. In 17 selected patients in whom PV/SMV invasion had been angiographically both semicircular or less and 1.2 cm (1.4 cm on the film) or less in length, the 3-year survival rate was 59%. This survival rate was significantly higher than the 29% 3-year survival rate in all 35 patients (p less than 0.05). Conversely, among the 18 patients in whom invasion was angiographically either beyond semicircular or more than 1.2 cm (1.4 cm on the film) in length, there were no 1.5-year survivors, and this result was even worse than that of 15 nonresectable cases. Based on postoperative survival, the degrees of PV/SMV invasion on preoperative angiography (narrowing pattern and length) are good indicators for aggressive pancreatectomy for locally advanced pancreatic cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1543394      PMCID: PMC1242425          DOI: 10.1097/00000658-199203000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Portal vein resection with a new antithrombogenic catheter.

Authors:  A Nakao; T Nonami; A Harada; T Kasuga; H Takagi
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  Appraisal of arteriography for assessment of operability in periampullary cancer.

Authors:  T Suzuki; T Tani; I Honjo
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  Survival of patients with cancer of the pancreas in relation to findings on arteriography.

Authors:  T Suzuki; K Kawabe; M Imamura; I Honjo
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

4.  Periampullary tumors: which ones should be resected?

Authors:  B A Jones; B Langer; B R Taylor; M Girotti
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

5.  Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.

Authors:  O Ishikawa; H Ohhigashi; Y Sasaki; T Kabuto; I Fukuda; H Furukawa; S Imaoka; T Iwanaga
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

6.  Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results.

Authors:  J G Fortner
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

7.  Collective review of small carcinomas of the pancreas.

Authors:  R Tsuchiya; T Noda; N Harada; T Miyamoto; T Tomioka; K Yamamoto; T Yamaguchi; K Izawa; T Tsunoda; R Yoshino
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

8.  Pancreaticoduodenectomy. A 40-year experience.

Authors:  J R Cohen; N Kuchta; N Geller; G T Shires; P Dineen
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

9.  Multimodality therapy of localized unresectable pancreatic adenocarcinoma.

Authors:  R Whittington; L Solin; M Mohiuddin; R I Cantor; F E Rosato; W A Biermann; S M Weiss; T F Pajak
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

10.  Chemotherapy of pancreatic carcinoma.

Authors:  S E Zimmerman; F P Smith; P S Schein
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more
  42 in total

Review 1.  Recent advances in the surgical treatment of pancreatic cancer.

Authors:  A Shankar; R C Russell
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  An Untapped Resource: Left Renal Vein Interposition Graft for Portal Vein Reconstruction During Pancreaticoduodenectomy.

Authors:  Thuy B Tran; Matthew W Mell; George A Poultsides
Journal:  Dig Dis Sci       Date:  2016-01-29       Impact factor: 3.199

Review 3.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma.

Authors:  Yong-Il Kim; Yong Joong Kim; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; Keon Wook Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-20       Impact factor: 9.236

Review 5.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

6.  Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study.

Authors:  M Nano; H Dal Corso; M Ferronato; M Solej; J P Hornung
Journal:  Surg Radiol Anat       Date:  2003-02-25       Impact factor: 1.246

7.  Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.

Authors:  Hop S Tran Cao; Alpana Balachandran; Huamin Wang; Graciela M Nogueras-González; Christina E Bailey; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Gauri Varadhachary; Christopher H Crane; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

8.  Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.

Authors:  Federico Selvaggi; Giuseppe Mascetta; Despoina Daskalaki; Marco dal Molin; Roberto Salvia; Giovanni Butturini; Carlo Cellini; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

Review 9.  Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Authors:  Markus Schäfer; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?

Authors:  L E Harrison; D S Klimstra; M F Brennan
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.